|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT02828163 |
|
Date of registration:
|
27/06/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Comparison Between Injections of Steroids and Autologous Platelet Rich Plasma in the Oral Erosions of Pemphigus Vulgaris
|
|
Scientific title:
|
Comparative Study Between Intralesional Autologous Platelet Rich Plasma and Intralesional Triamcinolone Acetonide in the Oral Erosions of Pemphigus Vulgaris Patients |
|
Date of first enrolment:
|
January 2016 |
|
Target sample size:
|
11 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02828163 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
|
|
Phase:
|
Phase 3
|
|
|
Countries of recruitment
|
|
Egypt
| | | | | | | |
|
Contacts
|
|
Name:
|
Mohamed HM EL-Komy, M.D |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Dermatology Department Cairo University |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Pemphigus vulgaris patients having bilateral erosions in the buccal mucosa.
Exclusion Criteria:
- Pemphigus vulgaris patients who do not have oral erosions.
- Pemphigus vulgaris patients who have received intralesional steroid injection in their
buccal mucosa.
Age minimum:
N/A
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Oral Pemphigus Vulgaris
|
|
Intervention(s)
|
|
Drug: Triamcinolone Acetonide
|
|
Other: Autologous Platelet rich plasma
|
|
Primary Outcome(s)
|
|
Improvement of the depth of oral erosions.
[Time Frame: 3 months]
|
|
Improvement of the size of oral erosions.
[Time Frame: 3 months]
|
|
Improvement of the degree of erythema of oral erosions.
[Time Frame: 3 months]
|
|
Secondary ID(s)
|
|
PRP # steroids in pemphigus
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|